Pf-03814735
Title | Journal |
---|---|
Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours. | European journal of cancer (Oxford, England : 1990) 20111001 |
PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy. | Molecular cancer therapeutics 20100401 |